CClinicalTrials.gg
CompletedNCT06202508MFUUpdated Jan 11, 2024

Fetal Death in Utero in the Internship Experience of Midwifery Students : an Unavoidable Experience?

An observational study in Fetal Death in Utero, sponsored by University Hospital, Strasbourg, France. Completed at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-01-11.

Sponsored by University Hospital, Strasbourg, France · Observational

Study type
Observational
Model
Case-only
Time perspective
Other
Enrollment
30
Ages
18 Years and older
Sex
All
01

Study summary

Fetal death in utero and the psychological and professional impact it could have on the midwifery student in training. Fetal death in utero corresponds to the spontaneous cessation of cardiac activity, from 14 weeks of amenorrhea.

For a large proportion of midwifery students, fetal death in utero is a situation encountered in the field. Despite the theoretical courses, a student does not expect to encounter this type of situation during the internship: it is delicate for both the supervising caregivers and the student. The purpose of this study is to demonstrate the impact that this situation could have on the midwifery student, both psychologically and in terms of their professional project.

Read the detailed description

The aim of the research is to highlight the psychological and professional impact of in utero fetal death among midwifery students in Strasbourg.

02

Conditions studied

  • Fetal Death in Utero

Browse trials for

Keywords

  • Fetal death in utero
03

In context

Fetal Death

87 studies on the registry are indexed under Fetal Death; 10 are open to participants now.

This study's enrollment of 30 is below the median of 100 across 41 observational studies indexed under Fetal Death.

Browse Fetal Death studies →

Lead sponsor

University Hospital, Strasbourg, France is the lead sponsor of 966 studies on the registry; 342 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Sampling method
Non-probability sample

Study population

Midwifery student of the Strasbourg school of medicine having experienced the discovery of a fetal death in utero in a birth room internship

Inclusion criteria

  • Age ≥18 years
  • Midwifery student of the Strasbourg school of medicine of 3rd year or more
  • having experienced the discovery of a fetal death in utero in a birth room internship
  • having participated in the follow-up of an in utero fetal death in the birth room
  • Agreed to participate in the interview and did not express opposition to the reuse of their data for the purpose of this research

Exclusion criteria

Exclusion Criteria:

  • Subject who expressed opposition to participating in the study
05

Study design

Observational model
Case-only
Time perspective
Other
Enrollment
30 participants (actual)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. To highlight the psychological and professional impact of in utero fetal death on Strasbourg midwifery students.

    Analysis of midwifery students' experiences during their internship in Strasbourg through semi-directive interviews

    Time frame: Approximately 10 months after a midwifery student was in charge of a case of fetal death in utero

07

Study locations

1 site
  • Service de Gynécologie Obstétrique - CHU de Strasbourg - France
    Strasbourg, 67091, France
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 11, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06202508
Lead sponsor
University Hospital, Strasbourg, France
Responsible party
Sponsor
First posted
Jan 11, 2024
Start date
Jun 18, 2021
Primary completion
Apr 18, 2022
Completion
Jun 18, 2022
Last update
Jan 11, 2024

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion